Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.54 |
| ▸ | CA1 | P00915 | 5/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | BIRC2 | Q13490 | 4/20 | 0.37 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 2/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27933679 | 0.98 | CA2 (0.53) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL29147476 | 0.90 | CA2 (0.44) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL28587684 | 0.88 | CA1 (0.40) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL27889133 | 0.86 | ZDHHC7 (0.41) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL27872754 | 0.86 | ZDHHC7 (0.41) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL29264683 | 0.85 | CA2 (0.43) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL31480565 | 0.85 | CA2 (0.43) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL29013172 | 0.85 | CA1 (0.56) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL27872771 | 0.84 | CA2 (0.64) | CA2CA1GAAMEN1KMT2A | |
| SCHEMBL30499378 | 0.84 | ACE2 (0.45) | CA2CA1GAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112469720-B | Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy | 艾科思莱德制药公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116322700-A | Novel PLK1 degradation inducing compounds | 厄普特拉株式会社 | 2023-06-23 | — | — | CN | disclosed |